Cargando…
BSCI-23 ANEUPLOIDY PROFILING IN GLIOBLASTOMA IDENTIFIES MECHANISMS OF DISEASE PROGRESSION AND TREATMENT VULNERABILITIES
Glioblastoma (GBM) is the most common and malignant adult brain tumor. Despite years of research, few advancements have been made in its management. One challenging area of glioblastoma research is patient stratification in clinical trials based on genomic features. Although several regions of aneup...
Autores principales: | Jermakowicz, Anna, Stukenberg, P Todd, Ayad, Nagi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354159/ http://dx.doi.org/10.1093/noajnl/vdac078.021 |
Ejemplares similares
-
BSCI-19 A LENTIVIRAL CRISPR SCREEN FOR EPIGENETIC MODULATORS OF ANTIGENS TARGETED BY CAR T CELLS IN GLIOBLASTOMA
por: Jordan Walter, T, et al.
Publicado: (2022) -
BSCI-02. METPlatform identifies brain metastasis vulnerabilities and predicts patient response to therapy
por: Zhu, Lucía, et al.
Publicado: (2021) -
BSCI-07 ACETYL-AMANTADINE AS A DIAGNOSTIC BIOMARKER IN PATIENTS WITH GLIOBLASTOMA
por: Mann, Anmol, et al.
Publicado: (2022) -
BSCI-03 THE ROLE OF LONP1 IN DRIVING ENHANCED PMT IN THE ‘LEADING EDGE’ NICHE IN GLIOBLASTOMA
por: Douglas, Christopher, et al.
Publicado: (2022) -
BSCI-05 REPURPOSING PROPOFOL FOR THE TREATMENT OF BRAIN METASTASES
por: Penning, Donald, et al.
Publicado: (2022)